Crohn Disease Diagnostics & Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Crohn's Disease Diagnostics and Therapeutics Market Analysis

The Crohn's disease diagnostics and therapeutics market is estimated to register a CAGR of 3.1% during the forecast period.

With the rise in COVID-19, the prevalence of other related complications also increased. According to a report by the SECURE-IBD database in January 2022, adverse COVID-19 outcomes were associated with age and other co-morbidities among patients with IBD. The novel severe acute respiratory syndrome-related coronavirus activated innate and adaptive immune responses upon entering the gastrointestinal tract. The study shows IBD patients' inflammatory reactions may cause intestinal damage. Also, a research article published in the Journal of Crohn and Colitis in March 2020 showed that IBD patients undertaking immune suppressors are associated with a greater risk of infections, even though there is no evidence to suggest that COVID-19 affects IBD patients more commonly than the general population. According to a review article in the World Journal of Gastroenterology in October 2020, it was comprehended that many COVID-19 patients were found to develop gastrointestinal complaints. Thus, there is an increasing demand for the Crohn's disease diagnostics and therapeutics market to manage further complications that could develop due to COVID-19.

The increasing occurrence of Crohn's disease is the primary driver predicted to boost the growth of the market. According to a report by the CDC published on World IBD Day in April 2021, the number of people affected by IBD is around 7 million worldwide. The report also stated that the rate of prevalence of the disease significantly increased during the last two decades. The prevalence of chronic health conditions such as cancer, arthritis, migraine, and other cardiovascular, respiratory, kidney, and liver diseases are higher in IBD patients than in non-IBD patients. In the older population (66 years and above), patients with IBD were more susceptible to hospitalization for hip fractures. Also, they were found to have 30-day readmissions, and more extended hospital stays. Studies on the treatment of IBD for the prevention of such instances are a great boost to the development of the market during the forecast period.

The increasing awareness of Crohn's disease, coupled with rising initiatives by regulatory bodies to develop novel treatment options, is expected to provide the market studied with high growth potential.

Crohn's Disease Diagnostics and Therapeutics Market Trends

This section covers the major market trends shaping the Crohns Disease Diagnostic & Therapeutic Market according to our research experts:

The Anti-inflammatory Agents Segment is Expected to Witness Significant Growth During the Forecast Period

Crohn's Disease Diagnostics and Therapeutics Industry Segmentation

Crohn's disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from the mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors in genetically predisposed individuals.

The Crohn's disease diagnostics and therapeutics market is segmented by diagnostics (blood test, fecal test, colonoscopy, flexible sigmoidoscopy, computerized tomography, magnetic resonance imaging, capsule endoscopy, other diagnostic tests), treatment (medication (anti-inflammatory agents, immunosuppressants, analgesics and antipyretics, other medications), surgery), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the market sizes and forecasts in terms of value in USD million for the above segments.